Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Javier Valle to Aged, 80 and over

This is a "connection" page, showing publications Javier Valle has written about Aged, 80 and over.

 
Connection Strength
 
 
 
0.362
 
  1. Valle JA, Li Z, Kosinski AS, Nelson AJ, Vemulapalli S, Cleveland J, Fullerton D, Messenger JC, Rove JY, Bricker RS, Bradley SM, Masoudi FA, Yeh RW, Armstrong EJ, Waldo SW, Carroll JD. Dissemination of Transcatheter Aortic Valve Replacement in the United States. J Am Coll Cardiol. 2021 08 24; 78(8):794-806.
    View in: PubMed
    Score: 0.089
  2. Valle JA, Miyasaka RL, Carroll JD. Acute Mitral Regurgitation Secondary to Papillary Muscle Tear: Is Transcatheter Edge-to-Edge Mitral Valve Repair a New Paradigm? Circ Cardiovasc Interv. 2017 06; 10(6).
    View in: PubMed
    Score: 0.066
  3. Valle JA, Shetterly S, Maddox TM, Ho PM, Bradley SM, Sandhu A, Magid D, Tsai TT. Postdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction: Insights From the HMO Research Network-Stent Registry. Circ Cardiovasc Interv. 2016 06; 9(6).
    View in: PubMed
    Score: 0.062
  4. Butala NM, Makkar R, Secemsky EA, Gallup D, Marquis-Gravel G, Kosinski AS, Vemulapalli S, Valle JA, Bradley SM, Chakravarty T, Yeh RW, Cohen DJ. Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results From the Transcatheter Valve Therapy Registry. Circulation. 2021 06 08; 143(23):2229-2240.
    View in: PubMed
    Score: 0.021
  5. McGuinn E, Warsavage T, Plomondon ME, Valle JA, Ho PM, Waldo SW. Association of Ischemic Evaluation and Clinical Outcomes Among Patients Admitted With New-Onset Heart Failure. J Am Heart Assoc. 2021 02; 10(5):e019452.
    View in: PubMed
    Score: 0.021
  6. Kokkinidis DG, Behan S, Jawaid O, Hossain P, Giannopoulos S, Singh GD, Laird JR, Valle JA, Waldo SW, Armstrong EJ. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes. Catheter Cardiovasc Interv. 2020 02 15; 95(3):439-446.
    View in: PubMed
    Score: 0.020
  7. Bricker RS, Glorioso TJ, Jawaid O, Plomondon ME, Valle JA, Armstrong EJ, Waldo SW. Temporal Trends and Site Variation in High-Risk Coronary Intervention and the Use of Mechanical Circulatory Support: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. J Am Heart Assoc. 2019 12 17; 8(24):e014906.
    View in: PubMed
    Score: 0.020
  8. Bricker RS, Valle JA, Plomondon ME, Armstrong EJ, Waldo SW. Causes of Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Qual Outcomes. 2019 05; 12(5):e005355.
    View in: PubMed
    Score: 0.019
  9. Mull HJ, Gellad ZF, Gupta RT, Valle JA, Makarov DV, Silverman T, Branch-Elliman W. Factors Associated With Emergency Department Visits and Hospital Admissions After Invasive Outpatient Procedures in the Veterans Health Administration. JAMA Surg. 2018 08 01; 153(8):774-776.
    View in: PubMed
    Score: 0.018
  10. Bradley SM, Liu W, Chan PS, Girotra S, Goldberger ZD, Valle JA, Perman SM, Nallamothu BK. Duration of resuscitation efforts for in-hospital cardiac arrest by predicted outcomes: Insights from Get With The Guidelines - Resuscitation. Resuscitation. 2017 04; 113:128-134.
    View in: PubMed
    Score: 0.016
  11. Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol. 2009 Apr; 2(2):129-34.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)